Early Global News . Friday . December 4, 2015

Early Global News . Friday . December 4, 2015

FB SNE GOOG HTC     Virtual Reality Market Getting Really Big   (The complete value of the virtual reality market, including hardware and software, will hit $70 billion within five years.)    re/code

TWTR  SiNA (not mentioned) China vows copyright protection for online news media  Reuters

SYUT     (MJN not mentioned)  Baby Formula Firms 'to Face Limit (3) on Number of Brands'   Caixin

LYV   (not mentioned) Facebook will now sell you concert tickets   Business Insider

Macau    WYNN LVS  (not mentioned)   Junket operators struggle to collect debts  Macau Business

Macau     Iao Kun (junket operator) November turnover US$330 mln, down 68 pct   Macau Business

Macau    Airport expansion expected to bring more passengers and cargo    Macau Daily Times

BABA   Alibaba Rakes in Singles' Day Sales   eMarketer

LMT  NOC  BA  RTN (not mentioned)   Japan defense budget likely to top 5 trillion yen for first time   Reuters

LMT   BA    Former U.S. official urges Pentagon to skip buying new ICBMs  Reuters

LMT     U.S. burning through bomb stockpiles on ISIL   USA Today

SSNLF    9 Samsung Executives Are Subject of Insider Trading Investigation   (South Korea regulator looking into potential illegal trading in Samsung C&T merger.)    NY Times

SWHC  RGR  Gun Industry Executives Say Mass Shootings Are Good for Business   The Intercept

FIZZ   ‘Sparkling’ LaCroix sales drive acquisition talk   NY Post

NOK   Nokia's $60,000 Virtual Reality Camera Goes On a Drone Test Flight  Slashdot

iTOCY   Japanese Trader Itochu Plans to Triple Number of Chinese-Speaking Employees    WSJ

ZPiN    Zhaopin Announces Strategic Cooperation with Zhong An Online Insurance  Press Release

YHOO     At Yahoo, Pressure for Change Tests Board's Loyalty to Mayer  WSJ

NVO      Novo Nordisk files for EU approval of faster-acting diabetes drug   Reuters

GiLD  European Medicines Agency Validates Gilead’s Marketing Application for Fixed-Dose Combination of Sofosbuvir/Velpatasvir for the Treatment of Hepatitis C   Press Release

NAVB     Navidea Biopharma reports results from an investigator-initiated imaging study demonstrated Lymphoseek reduced imaging time by more than 50%    Press Release

BiiB   Parents press Biogen for accessible medicines   Boston Globe

Contact  Mindy@EarlyGlobalNews.com